This contract developed data bases to supplement the Federal Employees Health Benefits Data used to develop the drug risk adjustment system for Medicare part D drug plans for low-income and disabled populations; explored geographic variation by state in drug prices and drug utilization; and examined the joint effects on drug plan risk of the combination of drug risk-adjustment, risk-corridors a
Prescription Drugs & Other Medical Products
Drugs and other medical products greatly impact human health and the health care system. ASPE conducts a variety of research in this area, including work related to medical product development and regulation; medical product markets, pricing and competition; prescription drug benefits and spending on medical products; medical product supply chains; and medical product safety.
Noteworthy
Reports
Displaying 141 - 150 of 160. 10 per page. Page 15.
Advanced SearchOptions for Defining Medicare Advantage Regions: An Assessment of Trade-offs
The Secretary of the Department of Health and Human Services (HHS) was charged with setting regional market areas for the implementation of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA).
Health Care in Transition: Technology Assessment in the Private Sector
Health Care in Transition: Technology Assessment in the Private Sector Prepared by: Richard Rettig of the RAND Corporation Office of the Assistant Secretary of Planning and Evaluation Agency for Health Care Policy and Research. July, 1996.
Pharmaceutical Pricing Practices, Utilization and Costs - Meeting Summary
By Kerry Kemp,Health Systems Research, Inc.
Medication Use in Long-Term Care Facilities and Community Settings for Medicare Beneficiaries with Cardiovascular Disease
This report compares medication use in long-term care facilities and community settings for Medicare beneficiaries with heart conditions. The purpose of this comparison was to evaluate the utility of a new file of institutional drug use in the Medicare Current Beneficiary Survey (MCBS), the premier source of health care information on the Medicare population.
The Contribution of Medication Use to Recent Trends in Old-Age Functioning
U.S. Department of Health and Human Services
Securing the Benefits of Medical Innovation for Seniors: The Role of Prescription Drugs and Drug Coverage
This report examines the consequences to medical innovation and overall health posed by attempts to contain drug expenditures by implementing government controls.
The Effects of Congressional Proposals on Prescription Drug Costs for Medicare Beneficiaries
Department of Health and Human Services Office of the Assistant Secretary for Public Affairs Provides discussion and estimates of several Congressional proposals on prescription drug costs for Medicare beneficiaries.
Medication Use by Medicare Beneficiaries Living in Nursing Homes and Assisted Living Facilities
This report compares the medication use of Medicare beneficiaries living in nursing homes and assisted living facilities. Descriptions of Medicare use include mean number of drug mentions per month of stay (scheduled and PRN drugs), and prevalence and duration of therapy by major drug classes.